Coronavirus: Commission secures an agreement with BioNTech-Pfizer to adapt delivery schedules to Member States' needs

Published on May 13, 2022

European Commission Press release Brussels, 13 May 2022 Today, the European Commission and the vaccine developers, BioNTech and Pfizer, reached an agreement to better address Member States needs for COVID-19 vaccines for the months ahead.

Continue reading on website
Other news

Video message for the Conference "Investments and Regions", high level panel "Cohesion Policy and Just Transition – perspectives for Bulgaria"

May 12, 2022
European Commission Speech Online, 13 May 2022 Dear colleagues,These days we were bluntly reminded that Europe's energy independence and transition to renewable energy sources is not only dictated by our cl...

ECHO Daily Map of 13 May 2022

May 13, 2022
Russia’s war on Ukraine| Civil Protection Response since 6 May 2022